BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 36142352)

  • 1. Circular RNAs Involved in the Regulation of the Age-Related Pathways.
    Wang S; Xiao F; Li J; Fan X; He Z; Yan T; Yang M; Yang D
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between circRNAs and the PI3K/AKT and/or MEK/ERK signaling pathways in digestive tract malignancy progression.
    Wu C; Huang X; Li M; Wang Z; Zhang Y; Tian B
    Future Oncol; 2022 Dec; 18(40):4525-4538. PubMed ID: 36891896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K/AKT/mTOR signaling pathway modulation by circular RNAs in breast cancer progression.
    Karami Fath M; Akhavan Masouleh R; Afifi N; Loghmani S; Tamimi P; Fazeli A; Mousavian SA; Falsafi MM; Barati G
    Pathol Res Pract; 2023 Jan; 241():154279. PubMed ID: 36584499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.
    Xue C; Li G; Lu J; Li L
    Signal Transduct Target Ther; 2021 Nov; 6(1):400. PubMed ID: 34815385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma.
    Liu W; Zhang J; Zou C; Xie X; Wang Y; Wang B; Zhao Z; Tu J; Wang X; Li H; Shen J; Yin J
    Cell Physiol Biochem; 2017; 43(3):969-985. PubMed ID: 28957794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
    Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentially expression and function of circular RNAs in ovarian cancer stem cells.
    Sohn EJ
    J Ovarian Res; 2022 Aug; 15(1):97. PubMed ID: 35978436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis.
    Jin T; Wang H; Liu Y; Wang H
    J Mol Med (Berl); 2024 Mar; 102(3):313-335. PubMed ID: 38265445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging miR-100 through the deactivation of PI3K/AKT and mTOR pathways in the renal carcinoma cell lines.
    Chen T; Shao S; Li W; Liu Y; Cao Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3638-3648. PubMed ID: 31456425
    [No Abstract]   [Full Text] [Related]  

  • 10. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 11. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
    El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
    Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNAs and Circular RNAs Regulate AKT and Its Effectors to Control Cell Functions of Cancer Cells.
    Tang JY; Chuang YT; Shiau JP; Yang KH; Chang FR; Hou MF; Farooqi AA; Chang HW
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic identification and characterization of circular RNAs involved in flag leaf senescence of rice.
    Huang X; Zhang H; Guo R; Wang Q; Liu X; Kuang W; Song H; Liao J; Huang Y; Wang Z
    Planta; 2021 Jan; 253(2):26. PubMed ID: 33410920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis.
    Wang L; Yang X; Zhou F; Sun X; Li S
    Bioengineered; 2022 Mar; 13(3):7197-7208. PubMed ID: 35263216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
    Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
    Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
    Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
    J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.